— Know what they know.
Not Investment Advice

ALKS NASDAQ

Alkermes plc
1W: -3.7% 1M: +9.5% 3M: +15.8% YTD: +30.8% 1Y: +16.7% 3Y: +19.1% 5Y: +66.0%
$36.80
-0.15 (-0.41%)
 
Weekly Expected Move ±6.0%
$33 $35 $37 $40 $42
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 66 · $6.1B mcap · 163M float · 1.48% daily turnover · Short 54% of daily vol

Cash Flow Trends

Operating Cash Flow
$521M +18.6% ▲
5Y CAGR: +44.4%
Capital Expenditures
$40M -20.7% ▼
5Y CAGR: -0.9%
Free Cash Flow
$480M +18.4% ▲
5Y CAGR: +63.9%
Dividends Paid
$0 +0.0% ▲
Buybacks
$31M +84.5% ▲
Net Change in Cash
$829M +598.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$48M-$158M$356M$367M$242M
Depreciation & Amort.$79M$78M$75M$29M$27M
Stock-Based Comp.$88M$94M$101M$97M$0
Change in Working Capital-$26M$13M-$37M-$98M$119M
Other Non-Cash Items$4M$27M$6M$5M$104M
Operating Cash Flow$102M$21M$401M$439M$521M
— Investing Activities —
Capital Expenditures-$29M-$38M-$48M-$33M-$40M
Acquisitions (Net)-$713K$485K$0$98M$3M
Investment Purchases-$340M-$310M-$254M-$487M-$364M
Investment Sales$295M$282M$356M$310M$697M
Other Investing$9M$1M$354K$461K$0
Investing Cash Flow-$66M-$65M$53M-$111M$295M
— Financing Activities —
Net Debt Issuance$20M-$3M-$3M-$292M$0
Stock Repurchased-$17M-$18M-$28M-$200M-$31M
Dividends Paid$0$0$0$0$0
Other Financing$0$0-$275M-$2M$0
Financing Cash Flow$29M-$2M-$290M-$494M$12M
Net Change in Cash$65M-$45M$165M-$166M$829M
Cash End of Period$338M$292M$457M$291M$1.1B
Free Cash Flow$73M-$17M$353M$406M$480M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms